Evidence review: economic issues

Evidence review: economic issues

Cost effectiveness

No cost-effectiveness studies were identified.


Ivermectin is unlicensed in the UK and can be supplied from 'special order' manufacturers or specialist importing companies. No costs could be obtained from standard published sources. Informal sources suggest that the cost is around £160 for 20×3 mg tablets.

The NHS Electronic Drug Tariff (January) lists the cost of permethrin 5% cream as £6.96 for 30 g and the cost of malathion 0.5% aqueous liquid (Derbac-M) as £2.37 for 50 ml and £5.93 for 200 ml. The British National Formulary lists the cost of 25% benzyl benzoate emulsion as £2.50 for 500 ml.

Current drug usage

The current usage of oral ivermectin for the treatment of scabies is unknown.